http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102133224-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e328f3403a32b1dbb56db1d343f262f5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
| filingDate | 2011-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53d690c64e8229fa79084680286417eb |
| publicationDate | 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102133224-B |
| titleOfInvention | Compound Iansoprazole chewable tablets |
| abstract | The invention relates to chewable tablets of a compound Iansoprazole pharmaceutical composition, which is prepared from Iansoprazole, sodium bicarbonate, magnesium hydroxide and special excipients for preparing chewable tablets pharmaceutically. According to the invention, the disintegration time limited, dissolution rate and taste of the compound Iansoprazole chewable tablets are better than that of other products in the prior art, unexpected technical effects are obtained, the product quality of the preparation is improved, and the toxic side effects are reduced. |
| priorityDate | 2011-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.